Gastroenterology
0 drugs are in development for Non-alcoholic Steatohepatitis.
- Companies
- 0
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Non-alcoholic Steatohepatitis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Non-alcoholic Steatohepatitis context
Gastroenterology·MeSH: Non-alcoholic Fatty Liver Disease (D065626)
Narrower concept of MeSH descriptor NAFLD
Prevalence
5000.0 / 100K
Incidence
500.0 / 100K/yr
Frequently asked questions
How many clinical trials target Non-alcoholic Steatohepatitis?
There are 7 clinical trials targeting Non-alcoholic Steatohepatitis tracked by BioSniper.
What is the prevalence of Non-alcoholic Steatohepatitis?
The estimated prevalence of Non-alcoholic Steatohepatitis is approximately 5000.0 per 100,000 population.